Results 101 to 110 of about 9,555,589 (295)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

The Worriers' Guild

open access: yesEmerging Infectious Diseases, 2005
Philip F. Deaver
doaj   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Mal de Mayo

open access: yesEmerging Infectious Diseases, 2007
Raymond T. Foster
doaj   +1 more source

Naufrage du mouvement liturgique contre les Alpes bernoises. Regard sur l’architecture sacrée en Valais

open access: yesArchAlp
In Hegel’s view, questioning the sacred seamlessly intertwines with the very essence of architecture – namely “that which binds together a multitude of souls”.
Patrick Giromini
doaj   +1 more source

The present state and future of the development of dimension stone mining in Slovak conditions [PDF]

open access: yesActa Montanistica Slovaca, 2005
In comparing to both ores and energetical minerals there are occurences of extremly rich non-methallics minerals on the Slovak territory. These minerals represent very large-scale sortiment with a considerable amount of verified reserves.
Viliam Žiaran, Viliam Bauer
doaj  

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Rats, Lice, and Zinsser

open access: yesEmerging Infectious Diseases, 2005
Gerald Weissmann
doaj   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Weeds

open access: yesEmerging Infectious Diseases, 2006
Ronald O. Valdiserri
doaj   +1 more source

Home - About - Disclaimer - Privacy